G Medical Innovations Stock Target Price
| GMVDDelisted Stock | USD 0.33 0.01 2.94% |
G Medical Innovations fundamentals help investors to digest information that contributes to G Medical's financial success or failures. It also enables traders to predict the movement of GMVD Stock. The fundamental analysis module provides a way to measure G Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to G Medical stock.
GMVD |
GMVD Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses G Medical's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of G Medical could also be used in its relative valuation, which is a method of valuing G Medical by comparing valuation metrics of similar companies.G Medical is currently under evaluation in target price category among its peers.
GMVD Fundamentals
| Return On Equity | -8.65 | |||
| Return On Asset | -2.23 | |||
| Operating Margin | (6.20) % | |||
| Current Valuation | 5.92 M | |||
| Shares Outstanding | 9.82 M | |||
| Shares Owned By Insiders | 15.28 % | |||
| Shares Owned By Institutions | 16.91 % | |||
| Number Of Shares Shorted | 68.79 K | |||
| Price To Book | 6.09 X | |||
| Price To Sales | 0.48 X | |||
| Revenue | 4.42 M | |||
| Gross Profit | 1.5 M | |||
| EBITDA | (37.75 M) | |||
| Net Income | (25.07 M) | |||
| Cash And Equivalents | 6.03 M | |||
| Cash Per Share | 0.25 X | |||
| Total Debt | 2.09 M | |||
| Debt To Equity | 0.44 % | |||
| Current Ratio | 1.03 X | |||
| Book Value Per Share | (4.82) X | |||
| Cash Flow From Operations | (18.48 M) | |||
| Short Ratio | 0.31 X | |||
| Earnings Per Share | (18.76) X | |||
| Target Price | 4.0 | |||
| Number Of Employees | 84 | |||
| Beta | -1.08 | |||
| Market Capitalization | 1.78 M | |||
| Total Asset | 4.83 M | |||
| Retained Earnings | (115.26 M) | |||
| Working Capital | (7.12 M) | |||
| Z Score | -59.61 | |||
| Net Asset | 4.83 M |
About G Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze G Medical Innovations's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of G Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of G Medical Innovations based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in GMVD Stock
If you are still planning to invest in G Medical Innovations check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the G Medical's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |